Literature DB >> 22280367

Fibulin-5 binds urokinase-type plasminogen activator and mediates urokinase-stimulated β1-integrin-dependent cell migration.

Alexander Kapustin1, Victoria Stepanova, Natalia Aniol, Douglas B Cines, Alexei Poliakov, Serge Yarovoi, Tatiana Lebedeva, Robin Wait, Grigory Ryzhakov, Yelena Parfyonova, Yaroslav Gursky, Hiromi Yanagisawa, Mikhail Minashkin, Robert Beabealashvilli, Alexander Vorotnikov, Alex Bobik, Vsevolod Tkachuk.   

Abstract

uPA (urokinase-type plasminogen activator) stimulates cell migration through multiple pathways, including formation of plasmin and extracellular metalloproteinases, and binding to the uPAR (uPA receptor; also known as CD87), integrins and LRP1 (low-density lipoprotein receptor-related protein 1) which activate intracellular signalling pathways. In the present paper we report that uPA-mediated cell migration requires an interaction with fibulin-5. uPA stimulates migration of wild-type MEFs (mouse embryonic fibroblasts) (Fbln5+/+ MEFs), but has no effect on fibulin-5-deficient (Fbln5-/-) MEFs. Migration of MEFs in response to uPA requires an interaction of fibulin-5 with integrins, as MEFs expressing a mutant fibulin-5 incapable of binding integrins (Fbln(RGE/RGE) MEFs) do not migrate in response to uPA. Moreover, a blocking anti-(human β1-integrin) antibody inhibited the migration of PASMCs (pulmonary arterial smooth muscle cells) in response to uPA. Binding of uPA to fibulin-5 generates plasmin, which excises the integrin-binding N-terminal cbEGF (Ca2+-binding epidermal growth factor)-like domain, leading to loss of β1-integrin binding. We suggest that uPA promotes cell migration by binding to fibulin-5, initiating its cleavage by plasmin, which leads to its dissociation from β1-integrin and thereby unblocks the capacity of integrin to facilitate cell motility.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22280367      PMCID: PMC4591041          DOI: 10.1042/BJ20110348

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  65 in total

1.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search.

Authors:  Andrew Keller; Alexey I Nesvizhskii; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2002-10-15       Impact factor: 6.986

2.  Urokinase plasminogen activator induces smooth muscle cell migration: key role of growth factor-like domain.

Authors:  V Stepanova; A Bobik; R Bibilashvily; A Belogurov; I Rybalkin; S Domogatsky; P J Little; E Goncharova; V Tkachuk
Journal:  FEBS Lett       Date:  1997-09-08       Impact factor: 4.124

Review 3.  The plasminogen activator/plasmin system.

Authors:  J D Vassalli; A P Sappino; D Belin
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

Review 4.  Gene targeting of components of the fibrinolytic system.

Authors:  Victoria A Ploplis; Francis J Castellino
Journal:  Thromb Haemost       Date:  2002-01       Impact factor: 5.249

5.  Proteolytic cleavage of single-chain pro-urokinase induces conformational change which follows activation of the zymogen and reduction of its high affinity for fibrin.

Authors:  S Kasai; H Arimura; M Nishida; T Suyama
Journal:  J Biol Chem       Date:  1985-10-05       Impact factor: 5.157

6.  Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1.

Authors:  L S Gutierrez; A Schulman; T Brito-Robinson; F Noria; V A Ploplis; F J Castellino
Journal:  Cancer Res       Date:  2000-10-15       Impact factor: 12.701

7.  Molecular analysis of fibulin-5 function during de novo synthesis of elastic fibers.

Authors:  Qian Zheng; Elaine C Davis; James A Richardson; Barry C Starcher; Tiansen Li; Robert D Gerard; Hiromi Yanagisawa
Journal:  Mol Cell Biol       Date:  2006-11-27       Impact factor: 4.272

8.  Activation of plasminogen by single-chain urokinase or by two-chain urokinase--a demonstration that single-chain urokinase has a low catalytic activity (pro-urokinase).

Authors:  R Pannell; V Gurewich
Journal:  Blood       Date:  1987-01       Impact factor: 22.113

9.  Fibulin-5 antagonizes vascular endothelial growth factor (VEGF) signaling and angiogenic sprouting by endothelial cells.

Authors:  Allan R Albig; William P Schiemann
Journal:  DNA Cell Biol       Date:  2004-06       Impact factor: 3.311

10.  Fibulins 3 and 5 antagonize tumor angiogenesis in vivo.

Authors:  Allan R Albig; Jason R Neil; William P Schiemann
Journal:  Cancer Res       Date:  2006-03-01       Impact factor: 12.701

View more
  9 in total

Review 1.  Fibulin-4 and fibulin-5 in elastogenesis and beyond: Insights from mouse and human studies.

Authors:  Christina L Papke; Hiromi Yanagisawa
Journal:  Matrix Biol       Date:  2014-03-06       Impact factor: 11.583

2.  Urokinase-type Plasminogen Activator (uPA) Promotes Angiogenesis by Attenuating Proline-rich Homeodomain Protein (PRH) Transcription Factor Activity and De-repressing Vascular Endothelial Growth Factor (VEGF) Receptor Expression.

Authors:  Victoria Stepanova; Padma-Sheela Jayaraman; Sergei V Zaitsev; Tatiana Lebedeva; Khalil Bdeir; Rachael Kershaw; Kelci R Holman; Yelena V Parfyonova; Ekaterina V Semina; Irina B Beloglazova; Vsevolod A Tkachuk; Douglas B Cines
Journal:  J Biol Chem       Date:  2016-05-04       Impact factor: 5.157

3.  Overexpression of Fibulin-5 Attenuates Ischemia/Reperfusion Injury After Middle Cerebral Artery Occlusion in Rats.

Authors:  Jia Guo; Chuang Cheng; Cindy Si Chen; Xiangfeng Xing; Guanghui Xu; Jinzhou Feng; Xinyue Qin
Journal:  Mol Neurobiol       Date:  2015-05-30       Impact factor: 5.590

4.  Effect of fibulin-5 on aldosterone-induced apoptosis in human ascending aortic smooth muscle cells.

Authors:  Yongji Yan; Xujie Liu; Xuanchen Li; Xuan Zhou; Chaozhi Yang; Jintao Tian; Jun Pu; Xiaoqun Niu
Journal:  Exp Ther Med       Date:  2021-06-23       Impact factor: 2.447

5.  Fibulin-3, -4, and -5 are highly susceptible to proteolysis, interact with cells and heparin, and form multimers.

Authors:  Jelena Djokic; Christine Fagotto-Kaufmann; Rainer Bartels; Valentin Nelea; Dieter P Reinhardt
Journal:  J Biol Chem       Date:  2013-06-19       Impact factor: 5.157

6.  Identification of the matricellular protein Fibulin-5 as a target molecule of glucokinase-mediated calcineurin/NFAT signaling in pancreatic islets.

Authors:  Tomoko Okuyama; Jun Shirakawa; Hiromi Yanagisawa; Mayu Kyohara; Shunsuke Yamazaki; Kazuki Tajima; Yu Togashi; Yasuo Terauchi
Journal:  Sci Rep       Date:  2017-05-24       Impact factor: 4.379

7.  Multifaced Roles of the Urokinase System in the Regulation of Stem Cell Niches.

Authors:  K V Dergilev; V V Stepanova; I B Beloglazova; Z I Tsokolayev; E V Parfenova
Journal:  Acta Naturae       Date:  2018 Oct-Dec       Impact factor: 1.845

8.  Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.

Authors:  Kangsheng Tu; Changwei Dou; Xin Zheng; Chao Li; Wei Yang; Yingmin Yao; Qingguang Liu
Journal:  BMC Cancer       Date:  2014-12-12       Impact factor: 4.430

9.  Dysregulation of fibulin-5 and matrix metalloproteases in epithelial ovarian cancer.

Authors:  Dustin B Manders; Hari Annavarapu Kishore; Adi F Gazdar; Patrick W Keller; Jun Tsunezumi; Hiromi Yanagisawa; Jayanthi Lea; Ruth Ann Word
Journal:  Oncotarget       Date:  2018-02-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.